Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations
about
Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations
description
scientific article published on 30 December 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2015
@uk
name
Switching Between Infliximab O ...... ease. Preliminary Observations
@en
Switching Between Infliximab O ...... ease. Preliminary Observations
@nl
type
label
Switching Between Infliximab O ...... ease. Preliminary Observations
@en
Switching Between Infliximab O ...... ease. Preliminary Observations
@nl
prefLabel
Switching Between Infliximab O ...... ease. Preliminary Observations
@en
Switching Between Infliximab O ...... ease. Preliminary Observations
@nl
P2093
P50
P356
P1476
Switching Between Infliximab O ...... ease. Preliminary Observations
@en
P2093
A Banaszkiewicz
E Toporowska-Kowalska
P304
P356
10.1093/ECCO-JCC/JJV233
P50
P577
2015-12-30T00:00:00Z